ZACTELGO Trademark

Trademark Overview


On Friday, May 7, 2021, a trademark application was filed for ZACTELGO with the United States Patent and Trademark Office. The USPTO has given the ZACTELGO trademark a serial number of 79313579. The federal status of this trademark filing is REGISTERED as of Tuesday, January 11, 2022. This trademark is owned by NOVARTIS AG. The ZACTELGO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro­ intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the...
zactelgo

General Information


Serial Number79313579
Word MarkZACTELGO
Filing DateFriday, May 7, 2021
Status700 - REGISTERED
Status DateTuesday, January 11, 2022
Registration Number6610377
Registration DateTuesday, January 11, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro­ intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Sunday, May 29, 2022NOTIFICATION PROCESSED BY IB
Tuesday, May 3, 2022FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 2, 2022FINAL DISPOSITION PROCESSED
Thursday, February 10, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, January 11, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 9, 2021ASSIGNED TO EXAMINER
Friday, July 9, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 9, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, July 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 9, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 6, 2021APPLICATION FILING RECEIPT MAILED
Friday, July 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 1, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, June 17, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB